From Bio
프롬바이오 · 377220
Consumer Staples Food & Beverage · KOSDAQ
Market cap US$15.5M (₩21.4B)
Overview
From Bio makes health supplements, vitamins, functional foods, and similar wellness products, for everyday consumers in South Korea and abroad.
It supplies these products directly to consumers through home-shopping channels, its own online store, and other digital platforms. Listed on KOSDAQ, Korea's tech and small-cap board, the company covers the full production chain in-house, from sourcing raw ingredients and developing functional formulas to manufacturing and distribution. Beyond supplements, it also conducts research into cell-culture and stem-cell technologies, and operates a separate cosmetics business.
Summary is AI-generated and may contain errors · figures from DART filings
Financials
Source: DART · FY ending Dec · latest FY2025Revenue
- FY2023US$48.4M
- FY2024US$48.7M
- FY2025US$52.3M
Operating profit
- FY2023−US$11.2M
- FY2024−US$17.6M
- FY2025−US$13.5M
Net income
- FY2023−US$8.4M
- FY2024−US$19M
- FY2025−US$16.8M
Key ratios (FY2025)
Why it matters
From Bio holds proprietary functional-ingredient approvals granted directly by Korea's Ministry of Food and Drug Safety, which underpin its core branded supplement products.
Price charts coming soon
Interactive price history isn't here yet. Would you use it?